- 首页
- ECHA 常见问答
- 详请
如果我不想向竞争对手透露我的身份,该怎么办?
问题(中文)
如果我不想向竞争对手透露我的身份,该怎么办?
Question (EN)
What should I do if I do not want to reveal my identity to my competitors?
中文内容由 Google Cloud Translation 自动生成,仅供参考;请以英文原文为准。问答资料来自欧盟化学品管理局(ECHA)官方网站。
答案(中文)
您可以指定第三方代表 (TPR) 代表您参与联合提交讨论和数据共享活动。这将使您的公司名称对其他共同注册人保密。注意:制造商或进口商在法律上仍为注册人。TPR 不得与第三方信息持有者(即数据持有者)或唯一代表混淆。TPR 也不得与为注册目的而保密注册人名称的可能性混淆(REACH 法规第 10(a)(xi) 条)。更多信息,请参阅数据共享指南第 2.1.3 节。问答 352 解释了如何在 REACH-IT 中分配 TPR。在查询过程中:我们会在 REACH-IT 的共同注册人页面上向注册人和成功的查询者显示 TPR 的联系方式。但是,我们会将查询结果告知查询人,而不是指定的 TPR。查询结果公布后/注册后:注册物质后,也可以指定一位 TPR 代表注册人进行数据共享协商。您可以通过更新注册档案来指定或更改您的 TPR。请参阅问答 0063。TPR 确保潜在注册人不会出现在共同注册人页面上。为了确保注册号授予后同一公司的保密性,请参阅问答 401。
Answer (EN)
You can nominate a Third Party Representative (TPR) to represent you in the joint submission discussions and in data sharing activities. This will keep your company name confidential vis-à-vis other co-registrants.NB: The manufacturer or importer legally remains the registrant. The TPR must not be confused with the third party holding information (i.e. data holders), nor with an Only Representative. The TPR must also not be confused with the possibility to keep confidential the registrant’s name for registration purposes (Article 10(a)(xi) REACH).For more information, see the Guidance on data sharing, section 2.1.3. Q&A 352 explains how to assign a TPR in REACH-IT.During the Inquiry process: We display on the co-registrants page in REACH-IT the contact details of the TPR to registrants and successful inquirers. However, we communicate the result of the inquiry process to the inquirer and not to a designated TPR.After the Inquiry result/ after Registration: It is also possible to appoint a TPR acting on behalf of the registrant after having registered a substance for data-sharing negotiations. You can appoint or change your TPR by updating your registration dossier. See Q&A 0063.A TPR ensures that the potential registrant does not appear on the co-registrants page. To ensure confidentiality of the same company after the registration number has been granted, see Q&A 401.